Isolation and use of human lymphoid organ-derived suppressive stromal cells

• 收藏
• 分享

专利权人:

The General Hospital Corporation D/B/A Massachusetts General Hospital; Inc.;Dana-Farber Cancer Institute;Dana-Farber Cancer Institute, Inc.

发明人:

Fletcher, Anne,Turley, Shannon J.,Parekkadan, Biju

申请号：

AU2018201195

公开号：

AU2018201195A1

申请日:

2018.02.20

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

#$%^&*AU2018201195A120180308.pdf#####ABSTRACT A method for suppressing an immune response is provided. The method involves administration of isolated lymphoid tissue-derived suppressive stromal cells (LSSC) to a subject in need of such treatment in an amount effective to suppress the immune response in the subject. The invention also involves a method to isolate LSSC by digesting lymphoid tissue fragments using a combination of an enzyme mix and agitation and then collecting the LSSC. Pharmaceutical preparations comprising LSSC are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/